Sarepta Therapeutics, Inc. SRPT Payment On Maturity Of Notes
Payment On Maturity Of Notes at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept srpt:PaymentOnMaturityOfNotes.
The official record: Sarepta Therapeutics, Inc.’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s payment on maturity of notes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s payment on maturity of notes?
- Sarepta Therapeutics, Inc. (SRPT) reported payment on maturity of notes of $0 in Q4 2025.
- How has Sarepta Therapeutics, Inc.'s payment on maturity of notes changed year-over-year?
- Sarepta Therapeutics, Inc.'s payment on maturity of notes decreased by 100.0% year-over-year, from $17K to $0.
- What does payment on maturity of notes mean?
- Represents the principal cash repayment made to debt holders upon the scheduled maturity of notes. This metric is a key indicator of the company's ability to meet its long-term debt obligations and manage its balance sheet maturity profile.